Age: 68.0
Sex: F
Vaccine: RSV
Symptoms: Injection site pain, Muscular weakness, Vertigo, Vision blurred
Clinical narrative: Jolt feeling in head; Legs collapsed; Fall; Headache right side and top of her head; Unable to stand; Vertigo; Unable to focus vision/ hard time focusing her eyesight; Woke up dizzy; Bruising at injection site; Pain at injection site.; Pain in eyes; Twitching in eyes; Loss of balance/ feel off balance; This non-serious case was reported by a consumer via call center representative and described the occurrence of injection site bruising in a 68-year-old female patient who received RSVPreF3 adjuvanted (Arexvy) for prophylaxis.   The patient's past medical history included headache.   On 18-JAN-2024 10:00, the patient received Arexvy. In JAN-2024, 3 days after receiving Arexvy, the patient experienced eye pain (Verbatim: Pain in eyes), blepharospasm (Verbatim: Twitching in eyes) and loss of balance (Verbatim: Loss of balance/ feel off balance). On 18-JAN-2024, the patient experienced injection site bruising (Verbatim: Bruising at injection site), injection site pain (Verbatim: Pain at injection site.), difficulty focusing eyes (Verbatim: Unable to focus vision/ hard time focusing her eyesight) and dizziness (Verbatim: Woke up dizzy). On 19-JAN-2024, the patient experienced vertigo (Verbatim: Vertigo). On 26-JAN-2024, the patient experienced brain zaps (Verbatim: Jolt feeling in head), lower extremities weakness of (Verbatim: Legs collapsed), fall (Verbatim: Fall), headache (Verbatim: Headache right side and top of her head) and difficulty in standing (Verbatim: Unable to stand). The outcome of the injection site bruising, injection site pain, vertigo and difficulty focusing eyes were resolving and the outcome of the eye pain, blepharospasm, brain zaps, lower extremities weakness of, fall and difficulty in standing were resolved and the outcome of the headache and loss of balance were not resolved and the outcome of the dizziness was unknown.   It was unknown if the reporter considered the injection site bruising, injection site pain, vertigo, difficulty focusing eyes, eye pain, blepharospasm, brain zaps, lower extremities weakness of, fall, headache, loss of balance, dizziness and difficulty in standing to be related to Arexvy.     It was unknown if the company considered the injection site bruising, injection site pain, vertigo, difficulty focusing eyes, eye pain, blepharospasm, brain zaps, lower extremities weakness of, fall, headache, loss of balance, dizziness and difficulty in standing to be related to Arexvy.   Additional Information: GSK Receipt Date: 31-Jan-2024 The patient was self-reported this case. The patient stated that she received Arexvy vaccine and had immediate pain and bruising at the injection site and that was slowly resolving.  The bruise and pain at injection site was not fully resolved.   The reporter stated that approximately 18 hours after she received her vaccine she woke up dizzy and had a hard time for focusing her eyesight.   The patient stated that she woke up the next morning with vertigo and poor focus became worse.   Patient stated that today her vertigo and poor focus had gotten better over time but had not resolved.   3 days after receiving her vaccination she had to hold on to walls to walk and experienced eye pain and eye twitching, she did call her physician at this point to report symptoms.   The reporter stated that on 26th January 2024 she experienced a jolt feeling in her head then her legs collapsed causing her to fall and she could not get up after the fall for a few minutes because she was unable to stand.  After falling on 26th January 2024 she had a headache right side and top of her head for the rest of the day.   The patient stated that she continues to feel off balance, dizzy, and had a mild headache that comes and goes. The reporter consented to follow up.